Management of Insulin Resistance

Lifestyle Interventions as Primary Treatment

Structured programs emphasizing lifestyle changes with education, reduced energy and fat intake (≤30% of total energy), regular physical activity, and consistent participant contact can produce long-term weight loss of 5-7% of starting weight, significantly improving insulin sensitivity independent of the mechanism, as recommended by the American Diabetes Association 1
The American Heart Association suggests that weight loss is the cornerstone of insulin resistance management, with a goal of 5-10% of body weight for overweight/obese individuals 1

The American College of Sports Medicine recommends at least 150 minutes per week of moderate-intensity aerobic exercise (50-70% of maximum heart rate), spread over at least 3 days with no more than 2 consecutive days without exercise, to improve insulin sensitivity 2
The American Diabetes Association suggests that resistance training at least twice per week involving all major muscle groups can improve insulin sensitivity to the same or greater extent as aerobic exercise 2
A combined approach of aerobic and resistance training can have additive benefits for improving insulin sensitivity, as recommended by the American College of Sports Medicine 2
For children and adolescents with insulin resistance, the American Academy of Pediatrics recommends at least 60 minutes of physical activity daily 2

The American Heart Association recommends the DASH (Dietary Approaches to Stop Hypertension) diet framework to guide nutritional interventions, emphasizing fruits, vegetables, low-fat dairy products, whole grains, poultry, fish, and nuts while reducing fats, red meat, sweets, and sugar-containing beverages 3
The American Diabetes Association advises against low-carbohydrate diets restricting total carbohydrate to <130 g/day, as long-term effects are unknown and impact on cardiovascular risk profile is uncertain 1

For patients with complications such as proliferative diabetic retinopathy or severe non-proliferative diabetic retinopathy, the American Diabetes Association recommends avoiding vigorous aerobic or resistance exercise that may trigger vitreous hemorrhage or retinal detachment 2
In severe peripheral neuropathy, the American Diabetes Association suggests avoiding treadmill, prolonged walking, jogging, and step exercises, and instead recommends swimming, bicycling, rowing, and chair exercises 4

Comprehensive cardiovascular risk reduction must remain a major focus of therapy, as insulin resistance is strongly associated with cardiovascular disease, hypertension, and dyslipidemia, as stated by the American Heart Association 3

The American Diabetes Association recommends beginning with comprehensive lifestyle modifications, including dietary changes, increased physical activity, and weight loss for overweight/obese individuals, to manage insulin resistance 5, 6
Target weight loss of 5-10% of body weight for overweight/obese individuals, which can significantly improve insulin sensitivity 7

The American Diabetes Association recommends metformin as the preferred first-line pharmacological agent for insulin resistance, particularly in patients with type 2 diabetes 5, 6, 8
Metformin should be started at a low dose (500 mg daily) with gradual titration (increasing by 500 mg every 1-2 weeks) to minimize gastrointestinal side effects, targeting an ideal dose of 2000 mg daily in divided doses 9

For patients presenting with significant hyperglycemic symptoms, markedly elevated plasma glucose, or HbA1c ≥10%, consider insulin therapy from the outset 5, 6
In older adults (≥65-70 years), focus on drug safety when selecting treatments, prioritizing strategies that minimize hypoglycemia risk, heart failure, renal dysfunction, bone fractures, and drug-drug interactions 7, 10
Less stringent glycemic targets (HbA1c <7.5-8.0%) may be appropriate for elderly patients with long-standing or complicated disease 7, 10
For obese patients, intensive lifestyle intervention should be emphasized, and GLP-1 receptor agonists are particularly beneficial due to their association with weight reduction 7
Insulin is the preferred medication for treating hyperglycemia in pregnancy, with target fasting glucose <95 mg/dL and either one-hour postprandial <140 mg/dL or two-hour postprandial <120 mg/dL 11, 12

Monitor HbA1c every 3 months until target is achieved, then at least twice yearly, and assess for improvement in markers of insulin resistance including fasting glucose, lipid profile, and blood pressure 5, 6
Comprehensive cardiovascular risk reduction must remain a major focus of therapy 5, 6, 8

For patients requiring large insulin doses due to severe insulin resistance, concentrated insulin preparations (U-500 regular insulin, U-300 glargine, U-200 degludec, U-200 lispro) may be more convenient and improve treatment adherence, as recommended by the American Diabetes Association 13, 14, 15
U-500 regular insulin is available in both prefilled pens and vials; other concentrated insulins are available only in prefilled pens to minimize dosing errors, according to the American Association of Clinical Endocrinologists 13, 14, 15
Consider insulin degludec/liraglutide (IDegLira) or insulin glargine/lixisenatide (iGlarLixi) for patients requiring both basal insulin and GLP-1 receptor agonist therapy, as suggested by the European Association for the Study of Diabetes [14] [14]